Clinical outcomes and Oncotype DX Breast Recurrence Score® in early‐stage BRCA‐associated hormone receptor‐positive breast cancer

BACKGROUND: BRCA‐associated breast cancers tend to have distinctive features compared to sporadic breast cancers; further characterization can aid in optimizing treatment. METHODS: The study evaluated a patient cohort with early‐stage estrogen receptor positive, HER2 negative invasive breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Layman, Rachel M., Lin, Heather, Gutierrez Barrera, Angelica M., Karuturi, Meghan S., Yam, Clinton, Arun, Banu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921901/
https://www.ncbi.nlm.nih.gov/pubmed/35128817
http://dx.doi.org/10.1002/cam4.4566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921901/
https://www.ncbi.nlm.nih.gov/pubmed/35128817
http://dx.doi.org/10.1002/cam4.4566

Ejemplares similares